Highlights
- Market Cap
- $3.26B
- Enterprise Value
- $3.06B
- EPS (TTM)
- -$6.56
- Total Revenue (TTM)
- $587.86M
- Gross Profit (TTM)
- $468.22M
- EBITDA (TTM)
- -$528.31M
- Year Range
- $30.08 - $62.18
- Target Price
- $56.78
- ROA (TTM)
- -70.93%
- ROE (TTM)
- -295.68%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Hinge Health, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Hinge Health, Inc
- 1D
- 4.87%
- 1M
- -9.82%
- YTD
- -16.99%
- 6M
- -21.43%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since May 22, 2025, HNGE's average daily return is +0.10%, while the average monthly return is +1.66%. At this rate, your investment would double in approximately 3.5 years.
Historically, 45% of months were positive and 55% were negative. The best month was Jun 2025 with a return of +33.2%, while the worst month was Jan 2026 at -24.9%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 3 months.
On a daily basis, HNGE closed higher 48% of trading days. The best single day was Aug 6, 2025 with a return of +25.6%, while the worst single day was Nov 5, 2025 at -15.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -24.87% | 22.52% | -9.82% | -16.99% | |||||||||
| 2025 | 3.41% | 33.24% | -13.14% | 24.76% | -12.48% | 1.39% | -1.71% | -5.03% | 23.67% |
Benchmark Metrics
Hinge Health, Inc has an annualized alpha of 5.04%, beta of 1.42, and R² of 0.07 versus S&P 500 Index. Calculated based on daily prices since May 23, 2025.
- This stock tended to rise when S&P 500 Index fell (downside capture of -97.33%), but participation in market rallies was also limited (-10.91%) — a profile typical of counter-cyclical assets.
- R² of 0.07 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 5.04%
- Beta
- 1.42
- R²
- 0.07
- Upside Capture
- -10.91%
- Downside Capture
- -97.33%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Hinge Health, Inc (HNGE) and compare them to a chosen benchmark (S&P 500 Index).
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Hinge Health, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Hinge Health, Inc was 48.52%, occurring on Feb 6, 2026. The portfolio has not yet recovered.
The current Hinge Health, Inc drawdown is 36.32%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -48.52% | Aug 7, 2025 | 127 | Feb 6, 2026 | — | — | — |
| -17.28% | May 28, 2025 | 13 | Jun 13, 2025 | 5 | Jun 23, 2025 | 18 |
| -16.77% | Jul 1, 2025 | 4 | Jul 7, 2025 | 22 | Aug 6, 2025 | 26 |
| -5.09% | Jun 25, 2025 | 1 | Jun 25, 2025 | 3 | Jun 30, 2025 | 4 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Hinge Health, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Hinge Health, Inc is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for HNGE relative to other companies in the Health Information Services industry. Currently, HNGE has a P/S ratio of 5.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |